Asset Details
Do you wish to reserve the book?
Clinical study on thalidomide combined with cinobufagin to treat lung cancer cachexia
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Clinical study on thalidomide combined with cinobufagin to treat lung cancer cachexia
Do you wish to request the book?
Clinical study on thalidomide combined with cinobufagin to treat lung cancer cachexia
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Clinical study on thalidomide combined with cinobufagin to treat lung cancer cachexia
2018
Overview
Objective: To discuss and assess the clinical value of treating lung cancer cachexia with thalidomide combined with cinobufagin.s
Methods: A cohort of 54 patients, who were diagnosed with lung carcinoma, was randomly divided into two groups, a trial group and a control group, respectively. The trial group was given 150 mg/day thalidomide and 2700 mg/day cinobufagin; the control group only received 2,700 mg/day cinobufagin. The therapy lasted for 12 weeks, and the nutritional status, quality of life, survival, and side effects in patients in the two groups were recorded.
Results: The nutritional status, quality of life, and survival of patients with lung cancer cachexia in the trial group were significantly improved compared to the control group. The trial group received 150 mg thalidomide, which by contrast reduced the incidence of side effect and increased tolerance.
Conclusion: Using thalidomide combined with cinobufagin to treat patients with lung cancer cachexia will significantly improve their nutritional status and quality of life. This therapy is better than that using cinobufagin alone and is well tolerated.
Publisher
Wolters Kluwer India Pvt. Ltd,Medknow Publications and Media Pvt. Ltd,Medknow Publications & Media Pvt. Ltd
Subject
/ Anorexia
/ Bufanolides - administration & dosage
/ Bufanolides - adverse effects
/ Bufanolides - therapeutic use
/ Cachexia
/ Complications and side effects
/ Female
/ Humans
/ Lung Neoplasms - complications
/ Male
/ Oncology
/ Patients
/ Steroids
/ Studies
/ Thalidomide - administration & dosage
/ Thalidomide - adverse effects
